Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erik Boman

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Plos One|May 17, 2011
Olfactory and visuospatial learning and memory performance in two strains of Alzheimer's disease model mice--a longitudinal studyMatthew Phillips, Erik Boman, Hanna Osterman, et al.
Philosophical Transactions. Series A, Mathematical, Physical, and Engineering Sciences|January 21, 2020
Preparing sparse solvers for exascale computingHartwig Anzt, Erik Boman, Rob Falgout, et al.
Science (New York, N.Y.)|May 7, 2021
Biosecurity for humanitarian aidMatthijs P van den Burg, Jennifer C Daltry, Baptiste Angin, et al.
Bioorganic & Medicinal Chemistry Letters|October 7, 2008
'Reverse' alpha-ketoamide-based p38 MAP kinase inhibitorsAntonio Garrido Montalban, Erik Boman, Chau-Dung Chang, et al.
Bioorganic & Medicinal Chemistry Letters|March 8, 2008
The design and synthesis of novel alpha-ketoamide-based p38 MAP kinase inhibitorsAntonio Garrido Montalban, Erik Boman, Chau-Dung Chang, et al.
European Journal of Pharmacology|February 6, 2010
KR-003048, a potent, orally active inhibitor of p38 mitogen-activated protein kinaseAntonio Garrido Montalban, Erik Boman, Chau-Dung Chang, et al.
Bioorganic & Medicinal Chemistry Letters|July 29, 2010
Optimization of alpha-ketoamide based p38 inhibitors through modifications to the region that binds to the allosteric siteAntonio Garrido Montalban, Erik Boman, Chau-Dung Chang, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Plos One|May 17, 2011
Olfactory and visuospatial learning and memory performance in two strains of Alzheimer's disease model mice--a longitudinal studyMatthew Phillips, Erik Boman, Hanna Osterman, et al.
Philosophical Transactions. Series A, Mathematical, Physical, and Engineering Sciences|January 21, 2020
Preparing sparse solvers for exascale computingHartwig Anzt, Erik Boman, Rob Falgout, et al.
Science (New York, N.Y.)|May 7, 2021
Biosecurity for humanitarian aidMatthijs P van den Burg, Jennifer C Daltry, Baptiste Angin, et al.
Bioorganic & Medicinal Chemistry Letters|October 7, 2008
'Reverse' alpha-ketoamide-based p38 MAP kinase inhibitorsAntonio Garrido Montalban, Erik Boman, Chau-Dung Chang, et al.
Bioorganic & Medicinal Chemistry Letters|March 8, 2008
The design and synthesis of novel alpha-ketoamide-based p38 MAP kinase inhibitorsAntonio Garrido Montalban, Erik Boman, Chau-Dung Chang, et al.
European Journal of Pharmacology|February 6, 2010
KR-003048, a potent, orally active inhibitor of p38 mitogen-activated protein kinaseAntonio Garrido Montalban, Erik Boman, Chau-Dung Chang, et al.
Bioorganic & Medicinal Chemistry Letters|July 29, 2010
Optimization of alpha-ketoamide based p38 inhibitors through modifications to the region that binds to the allosteric siteAntonio Garrido Montalban, Erik Boman, Chau-Dung Chang, et al.
Pageof 1